Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2006-12-21
2010-02-02
Jung, Unsu (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S004000, C435S007100, C435S007920, C436S149000, C436S164000, C436S172000, C422S068100, C422S082010, C422S082050, C422S082060, C422S082070, C422S082080, C424S130100, C424S133100, C424S141100
Reexamination Certificate
active
07655428
ABSTRACT:
The present invention relates to methods and compositions for measuring latent protein C in test samples, particularly patient samples. The methods and compositions described are sensitive for latent protein C, relative to activated protein C.
REFERENCES:
patent: 5460953 (1995-10-01), Gerlitz et al.
patent: 5965375 (1999-10-01), Valkirs
patent: 6207395 (2001-03-01), Valkirs et al.
patent: 6503722 (2003-01-01), Valkirs
patent: 6828110 (2004-12-01), Lee et al.
patent: 6908739 (2005-06-01), Buechler et al.
patent: 7052858 (2006-05-01), Gray et al.
patent: 7329738 (2008-02-01), Lee et al.
patent: 7374888 (2008-05-01), Valkirs et al.
patent: 7393647 (2008-07-01), Valkirs et al.
patent: 2003/0186862 (2003-10-01), Nelsestuen
patent: 2005/0148029 (2005-07-01), Buechler et al.
patent: 2005/0164238 (2005-07-01), Valkirs et al.
patent: 2005/0196817 (2005-09-01), Kingsmore et al.
patent: 2008/0050832 (2008-02-01), Buechler et al.
patent: 2008/0124747 (2008-05-01), Valkirs et al.
patent: 2009/0004755 (2009-01-01), Lee et al.
patent: WO 2007/011722 (2007-01-01), None
patent: WO 2007011722 (2007-01-01), None
patent: WO 2007/011722 (2007-06-01), None
McCoy et al., “Drotrecogin alfa (recombinant human activated protein C) for the treatment of severe sepsis,” Clinical Therapeutics, 2003, vol. 25, pp. 396-421.
Chognot, et al. Identification of protein C epitopes altered during its nanoencapsulation. J Protein Chem. Oct. 1999;18(7):779-84.
International Search Report dated May 29, 2008 from PCT Application No. US2006/062517.
Macias, et al. Severe protein C deficiency predicts early death in severe sepsis. Crit Care Med. May 2004;32(5 Suppl):S223-8.
Mesters, et al. Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications. Crit Care Med. Jul. 2000;28(7):2209-16.
Vincenot, et al. A monoclonal antibody recognizing the activation domain of protein C in its calcium-free conformation. FEBS Lett. Jul. 31, 1998;432(1-2):94-7.
Yan, et al. Low levels of protein C are associated with poor outcome in severe sepsis. Chest. Sep. 2001;120(3):915-22.
Office action issued May 29, 2009 for U.S. Appl. No. 11/543,312.
Buechler Joseph A.
Lee Seok-Won
Valkirs Gunars E.
Veeramallu Uday Kumar
Biosite, Inc.
Jung Unsu
Wilson Sonsini Goodrich & Rosati
LandOfFree
Latent protein C assays and their uses for diagnosis and/or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Latent protein C assays and their uses for diagnosis and/or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Latent protein C assays and their uses for diagnosis and/or... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4225925